NEW YORK (Reuters Health) – Temperature lowering, either by pharmacologic or physical means, does not improve stroke outcomes, according to a review of trial data. Prior research has…
NEW YORK (Reuters Health) – Compared with a strategy of optimal medical therapy alone for treatment of stable coronary artery disease (CAD), the addition of percutaneous coronary intervention…
NEW YORK (Reuters Health) – Although the rate of hysterectomy after cesarean delivery has declined over the past decade, the procedure remains an “uncommon, but not rare” complication…
NEW YORK (Reuters Health) – Pitavastatin is equivalent to atorvastatin in its ability to reduce coronary plaque volume in patients with acute coronary syndrome (ACS), Japanese researchers have…
NEW YORK (Reuters Health) – For patients with cerebral ischemia, treatment with tissue plasminogen activator (TPA) is known to confer substantial benefit when given within 3 hours of…
NEW YORK (Reuters Health) – When patients with acute coronary syndromes receive non-drug-eluting, carbon-coated stents, the rate of binary angiographic restenosis rate at 6 months is low, according…
NEW YORK (Reuters Health) – Findings from the Cardiovascular Health Study-Cognition Substudy suggest that angiotensin-converting enzyme (ACE) inhibitors that cross the blood-brain barrier reduce the risk of incident…
NEW YORK (Reuters Health) – The mortality risk associated with heart failure is increased in indigent patients with comorbid metabolic syndrome, new study findings indicate. “Metabolic syndrome is…
NEW YORK (Reuters Health) – Adults with a history of low birth weight (LBW) are more prone to respiratory illnesses requiring hospitalization than are adults without such a…
NEW YORK (Reuters Health) – New research indicates that whether hemodialysis is given early or delayed has no bearing on morbidity or mortality in patients with end-stage renal…